Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows – operating activities:
Net loss	$ (7,968)	$ (2,212)
Non-cash items –
Share-based plans expense	310	548
Treasury shares issued for 401(k) contribution	1,315	1,204
Depreciation and amortization	1,327	1,380
Investment/asset impairment charges, net	48	12
Gain on dispositions, net	(5)	(1)
777X and 767 reach-forward losses	3,006
Other charges and credits, net	270	(25)
Changes in assets and liabilities –
Accounts receivable	(275)	(523)
Unbilled receivables	(1,042)	(547)
Advances and progress billings	1,666	2,963
Inventories	(6,854)	(940)
Other current assets	(26)	707
Accounts payable	122	982
Accrued liabilities	327	(574)
Income taxes receivable, payable and deferred	(282)	73
Other long-term liabilities	(228)	(254)
Pension and other postretirement plans	(736)	(785)
Financing receivables and operating lease equipment, net	258	472
Other	137	99
Net cash (used)/provided by operating activities	(8,630)	2,579
Cash flows – investing activities:
Payments to acquire property, plant and equipment	(1,582)	(1,096)
Proceeds from disposals of property, plant and equipment	46	19
Acquisitions, net of cash acquired	(50)	(19)
Contributions to investments	(1,751)	(14,485)
Proceeds from investments	4,546	10,497
Supplier notes receivable	(494)	(162)
Repayments on supplier notes receivable	40
Purchase of distribution rights	(88)
Other	(14)	5
Net cash provided/(used) by investing activities	653	(5,241)
Cash flows – financing activities:
New borrowings	10,120	55
Debt repayments	(4,824)	(5,181)
Stock options exercised		45
Employee taxes on certain share-based payment arrangements	(73)	(52)
Other	15	2
Net cash provided/(used) by financing activities	5,238	(5,131)
Effect of exchange rate changes on cash and cash equivalents	8	(22)
Net decrease in cash & cash equivalents, including restricted	(2,731)	(7,815)
Cash & cash equivalents, including restricted, at beginning of year	12,713	14,647
Cash & cash equivalents, including restricted, at end of period	9,982	6,832
Less restricted cash & cash equivalents, included in Investments	21	21
Cash and cash equivalents at end of period	$ 9,961	$ 6,811